awmsg logo



sevelamer carbonate (Renvela®)


Reference No. 446

Publication date:
19/01/2011


Appraisal information

sevelamer carbonate (Renvela®) 2.4 g powder for oral solution


Company: Genzyme Therapeutics
BNF category: Nutrition and blood
NMG meeting date: Not scheduled
AWMSG meeting date: Not scheduled
   
   
Submission Type: Nonsubmission
Status: Not endorsed
Advice No: Not available
Ratification by Welsh Government: Not available

Current Progress


Submission
received
NMG
meeting
AWMSG
meeting
Ratification by
Welsh Government

AWMSG advice

In the absence of a submission from the holder of the marketing authorisation, sevelamer carbonate (Renvela®) powder for oral suspension cannot be endorsed for use within NHS Wales for the control of hyperphosphataemia in adult patients receiving haemodialysis or peritoneal dialysis and in those with chronic kidney disease not on dialysis.
Statement of Advice (SOA)
Download